Blue water vaccines announces collaboration with instituto butantan for the development of bwv-101, a universal influenza vaccine candidate

Cincinnati, may 19, 2022 (globe newswire) -- blue water vaccines, inc. (“bwv” or “blue water vaccines” or “the company”) a biopharmaceutical company developing vaccines, announces a collaboration with the multidisciplinary center for r&d in immunobiologics (“cerdi”), an initiative of instituto butantan (“butantan”). through this partnership, butantan, a leading brazilian producer of immunobiologic products and vaccines, and bwv will develop the universal influenza vaccine candidate, bwv-101, in brazil.
BWV Ratings Summary
BWV Quant Ranking